Back to SMMT

Kynam Capital Management, LP → SMMT

Kynam Capital Management, LP SMMT Position History

Summit Therapeutics Inc. • Healthcare

Quarters held
2
Latest value
$50.7M
Q3 2026
Peak value
$50.7M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$17.5M
Q3 2026$50.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$50.7M3.00M——
Q2 2026$17.5M1.20M——

Other funds holding SMMT

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M